Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Current Debt: 2009-2010

Historic Current Debt for Cytokinetics (CYTK) over the last 2 years, with Dec 2010 value amounting to $174.6 million.

  • Cytokinetics' Current Debt rose 2.60% to $180.9 million in Q1 2011 from the same period last year, while for Mar 2011 it was $167.7 million, marking a year-over-year decrease of 58.89%. This contributed to the annual value of $174.6 million for FY2010, which is 49.89% up from last year.
  • Per Cytokinetics' latest filing, its Current Debt stood at $174.6 million for FY2010, which was up 49.89% from $116.5 million recorded in FY2009.
  • In the past 5 years, Cytokinetics' Current Debt ranged from a high of $174.6 million in FY2010 and a low of $116.5 million during FY2009.
  • In the last 2 years, Cytokinetics' Current Debt had a median value of $145.6 million in 2009 and averaged $145.6 million.
  • Data for Cytokinetics' Current Debt shows a peak YoY skyrocketed of 49.89% (in 2010) over the last 5 years.
  • Yearly analysis of 2 years shows Cytokinetics' Current Debt stood at $116.5 million in 2009, then surged by 49.89% to $174.6 million in 2010.